The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and management
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cholesterol Modification of Hedgehog Signaling Proteins in Animal Development
Porter, J. A., Young, K. E., & Beachy, P. A. (1996) · Science · doi:10.1126/science.274.5285.255 · Cited by 1,360
A newly recognized syndromeof multiple congenital anomalies
Smith, D. W., Lemli, L., & Opitz, J. M. (1964) · The Journal of Pediatrics · doi:10.1016/s0022-3476(64)80264-x · Cited by 650
The Smith-Lemli-Opitz syndrome
Kelley, R. I., & Hennekam, R. C. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.5.321 · Cited by 480
Mutations in the Human Sterol Δ7-Reductase Gene at 11q12-13 Cause Smith-Lemli-Opitz Syndrome
Wassif, C. A., Maslen, C., Kachilele-Linjewile, S., Lin, D., Linck, L. M., Connor, W. E., Steiner, R. D., & Porter, F. D. (1998) · The American Journal of Human Genetics · doi:10.1086/301936 · Cited by 418
Self-citationA defective response to Hedgehog signaling in disorders of cholesterol biosynthesis
Cooper, M. K., Wassif, C. A., Krakowiak, P. A., Taipale, J., Gong, R., Kelley, R. I., Porter, F. D., & Beachy, P. A. (2003) · Nature Genetics · doi:10.1038/ng1134 · Cited by 390
Self-citationMutations in the Δ7-sterol reductase gene in patients with the Smith–Lemli–Opitz syndrome
Fitzky, B. U., Witsch-Baumgartner, M., Erdel, M., Lee, J. N., Paik, Y.-K., Glossmann, H., Utermann, G., & Moebius, F. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8181 · Cited by 384
Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome
Irons, M., Roy Elias, E., Salen, G., Tint, G. S., & Batta, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90983-n · Cited by 368
Repression of Smoothened by Patched-Dependent (Pro-)Vitamin D3 Secretion
Bijlsma, M. F., Spek, C. A., Zivkovic, D., van de Water, S., Rezaee, F., & Peppelenbosch, M. P. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040232 · Cited by 314
Smith-Lemli-Opitz Syndrome Is Caused by Mutations in the 7-Dehydrocholesterol Reductase Gene
Waterham, H. R., Wijburg, F. A., Hennekam, R. C. M., Vreken, P., Poll-The, B. T., Dorland, L., Duran, M., Jira, P. E., Smeitink, J. A. M., Wevers, R. A., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301982 · Cited by 296
Kelley, R. I. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06038-4 · Cited by 234
Molecular cloning and expression of the human Δ7-sterol reductase
Moebius, F. F., Fitzky, B. U., Lee, J. N., Paik, Y.-K., & Glossmann, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1899 · Cited by 221
Kelley, R. I., Roessler, E., Hennekam, R. C. M., Feldman, G. L., Kosaki, K., Jones, M. C., Palumbos, J. C., & Muenke, M. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19961230)66:4<478::aid-ajmg22>3.0.co;2-q · Cited by 219
Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome
Tierney, E., Nwokoro, N. A., Porter, F. D., Freund, L. S., GHUMAN, J. K., & Kelley, R. I. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010115)98:2<191::aid-ajmg1030>3.0.co;2-m · Cited by 198
Self-citationThe near universal presence of autism spectrum disorders in children with Smith–Lemli–Opitz syndrome
Sikora, D. M., Pettit‐Kekel, K., Penfield, J., Merkens, L. S., & Steiner, R. D. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31294 · Cited by 196
Fitzky, B. U., Moebius, F. F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., Maeda, N., Kluckman, K. D., Hiller, S., Yu, H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12103 · Cited by 177
Elias, E. R., Irons, M., Hurley, A. D., Tint, G. S., & Salen, G. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970131)68:3<305::aid-ajmg11>3.0.co;2-x · Cited by 172
Wassif, C. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.555 · Cited by 164
Megha, M., Bakht, O., & London, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600395200 · Cited by 160
Fitzky, B. U., Moebius, F. F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., Maeda, N., Kluckman, K. D., Hiller, S., Yu, H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112103 · Cited by 153
Treatment of Smith-Lemli-Opitz syndrome: Results of a multicenter trial
Irons, M., Elias, E. R., Abuelo, D. N., Bull, M. J., Greene, C. L., Johnson, V. P., Keppen, L. D., Schanen, C., Tint, G. S., & Salen, G. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970131)68:3<311::aid-ajmg12>3.0.co;2-w · Cited by 140
Simvastatin: a new therapeutic approach for Smith-Lemli-Opitz syndrome
Jira, P. E., Wevers, R. A., de Jong, J. G. N., Rubio‐Gozalbo, M. E., Janssen-Zijlstra, F. S. M., van Heyst, A. F. J., Sengers, R. C. A., & Smeitink, J. A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33442-8 · Cited by 118
Keller, R. K., Arnold, T. P., & Fliesler, S. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300232-jlr200 · Cited by 113
Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome
Craig, W. Y., Haddow, J. E., Palomaki, G. E., Kelley, R. I., Kratz, L. E., Shackleton, C. H. L., Marcos, J., Tint, G. S., MacRae, A. R., Nowaczyk, M. J. M., et al. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1518 · Cited by 111
3β-Hydroxysterol Δ7-reductase and the Smith–Lemli–Opitz syndrome
Correa-Cerro, L. S., & Porter, F. D. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.017 · Cited by 92
Self-citationGondré‐Lewis, M. C., Petrache, H. I., Wassif, C. A., Harries, D., Parsegian, A., Porter, F. D., & Loh, Y. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02906 · Cited by 92
Self-citationCholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome
Sikora, D. M., Ruggiero, M., Pettit-Kekel, K., Merkens, L. S., Connor, W. E., & Steiner, R. D. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.036 · Cited by 89
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome
Witsch‐Baumgartner, M., Gruber, M., Kraft, H. G., Rossi, M., Clayton, P. T., Girós, M., Haas, D., Kelley, R. I., Krajewska-Walasek, M., & Utermann, G. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018085 · Cited by 88
Effects of cholesterol and simvastatin treatment in patients with Smith–Lemli–Opitz syndrome (SLOS)
Haas, D., Garbade, S. F., Vohwinkel, C. U., Muschol, N., Trefz, F. K., Penzien, J. M., Zschocke, J., Hoffmann, G. F., & Burgard, P. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0537-7 · Cited by 78
Nowaczyk, M. J. M., Waye, J. S., & Douketis, J. D. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31413 · Cited by 78
Correa-Cerro, L. S., Wassif, C. A., Kratz, L., Miller, G. F., Munasinghe, J. P., Grinberg, A., Fliesler, S. J., & Porter, F. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl003 · Cited by 75
Self-citationKovářová, M., Wassif, C. A., Odom, S., Liao, K. P., Porter, F. D., & Rivera, J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051701 · Cited by 75
Self-citationWitsch‐Baumgartner, M., Ciara, E., Löffler, J., Hj, M., Seedorf, U., Burn, J., Gillessen‐Kaesbach, G., Hoffmann, G. F., Fitzky, B., Mundy, H. R., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200579 · Cited by 74
Koide, T., Hayata, T., & Cho, K. W. Y. (2006) · Development · doi:10.1242/dev.02393 · Cited by 69
Wolthers, B., Walrecht, H., der Molen, J. C. V., Nagel, G. T., van Doormaal, J., & Wijnandts, P. N. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42047-4 · Cited by 69
Wassif, C. A., Krakowiak, P. A., Wright, B. S., Gewandter, J. S., Sterner, A. L., Javitt, N. B., Yergey, A. L., & Porter, F. D. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.12.009 · Cited by 67
Self-citationSingh, P., Paila, Y. D., & Chattopadhyay, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.135 · Cited by 67
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
Tulenko, T. N., Boeze-Battaglia, K., Mason, R. P., Tint, G. S., Steiner, R. D., Connor, W. E., & LaBelle, E. F. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500306-jlr200 · Cited by 64
Steiner, R. D., Linck, L. M., Flavell, D. P., Lin, D. S., & Connor, W. E. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33456-8 · Cited by 62
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations
Witsch‐Baumgartner, M., Schwentner, I. M., Gruber, M., Benlian, P., Bertranpetit, J., Bieth, É., Chevy, F., Clusellas, N., Estivill, X., Gasparini, G., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.053520 · Cited by 61
Bradley, L., Palomaki, G. E., Knight, G. J., Haddow, J. E., Optiz, J. M., Irons, M., Kelley, R. I., & Tint, G. S. (1999) · American Journal of Medical Genetics · Cited by 61
Shackleton, C., Roitman, E., Guo, L.-W., Wilson, W. K., & Porter, F. D. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00155-3 · Cited by 56
Self-citationCorrea-Cerro, L. S., Wassif, C. A., Waye, J. S., Krakowiak, P. A., Cozma, D., Dobson, N. R., Levin, S. W., Anadiotis, G., Steiner, R. D., Krajewska‐Walasek, M., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.022749 · Cited by 56
Self-citationCholesterol storage defect in RSH/Smith–Lemli–Opitz syndrome fibroblasts
Wassif, C. A., Vied, D., Tsokos, M., Connor, W. E., Steiner, R. D., & Porter, F. D. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00010-0 · Cited by 55
Self-citationMarcos, J., Guo, L., Wilson, W. K., Porter, F. D., & Shackleton, C. H. L. (2003) · Steroids · doi:10.1016/j.steroids.2003.09.013 · Cited by 49
Self-citationNishino, H., & Ishibashi, T. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1602 · Cited by 48
Shackleton, C. H. L., Marcos, J., Palomaki, G. E., Craig, W. Y., Kelley, R. I., Kratz, L. E., & Haddow, J. E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31901 · Cited by 46
Wassif, C. A., Yu, J., Cui, J., Porter, F. D., & Javitt, N. B. (2003) · Steroids · doi:10.1016/s0039-128x(03)00090-4 · Cited by 44
Self-citationSimvastatin treatment in the SLO syndrome: A safe approach?
Starck, L., Lövgren‐Sandblom, A., & Björkhem, I. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10722 · Cited by 42
Shackleton, C. H. L., Roitman, E., Kratz, L. E., & Kelley, R. I. (1999) · Steroids · doi:10.1016/s0039-128x(99)00026-4 · Cited by 31
Founder effect for the T93MDHCR7mutation in Smith‐Lemli‐Opitz syndrome
Nowaczyk, M. J. M., Martín-García, D., Perna, A. A. A., Rodríguez-Vázquez, M., McCaughey, D., Eng, B., Nakamura, L. N., & Waye, J. S. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20676 · Cited by 20
Andersson (1999) · doi:10.1002/(sici)1096-8628(19990219)82:5 · Cited by 1
Cited by
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Self-citation7-Dehydrocholesterol dictates ferroptosis sensitivity
Li, Y., Ran, Q., Duan, Q., Jin, J., Wang, Y., Yu, L., Wang, C., Zhu, Z., Chen, X., Weng, L., et al. (2024) · Nature · doi:10.1038/s41586-023-06983-9 · Cited by 367
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
HDL and cholesterol handling in the brain
Vitali, C., Wellington, C. L., & Calabresi, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu148 · Cited by 254
Metadata
- Authors
- Porter, F. D.
- Venue
- European Journal of Human Genetics
- Published
- 2008-02-20
- Volume
- 16
- Issue
- 5
- Pages
- 535-541
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W1510119345
- Cited by
- 319
- References
- 51
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.